Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013


Bioinorganic Chemistry Conference 2013

19 Feb 2013 - 22 Feb 2013 - Lanzarote, Spain



Bookmark and Share


Metals are receiving ever-increasing recognition for their roles in biological processes. It is estimated that over one third of all proteins contain at least one metal ion as essential prosthetic group, and it is well recognized that those metallobiomolecules are of key importance for a large number of biological reactions and phenomena, including electron transfer, oxidation reactions involved in metabolism and catabolism, hydrolysis reactions, synthesis and metabolic function of genes, regulation of protein expression, cell signalling, etc.. A detailed understanding of the regulation and molecular mechanisms of metalloprotein function is not only of fundamental interest, but is of great importance to the pharmaceutical, agricultural, biotechnological, and environmental industries. In the end it may also pave the way for various technological applications of the principles of biocatalysis, since metalloenzymes are capable of carrying out energetically difficult chemical transformations (such as the fixation of dinitrogen to ammonia or the oxidation of methane to methanol) under mild and environmentally safe conditions. Emulating the unique reactivity of metalloenzymes by small synthetic complexes for the ultimate goal of catalytic applications is thus a formidable task. This conference now brings together chemists, biologists and biophysicists that interrogate the role of metal ions in biological systems, using both experimental and theoretical approaches. The conference provides a stimulating and interdisciplinary environment for both senior scientists and young researchers to discuss latest progress in the field of bioinorganic chemistry, with topics ranging from structural biology to bioinspired coordination chemistry and medicinal applications of metallodrugs.



Further information
Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!